Literature DB >> 2968201

Defective T-cell colony formation and IL-2 receptor expression at all stages of HIV infection.

A Winkelstein1, L A Kingsley, R S Klein, D W Lyter, T L Evans, C R Rinaldo, L D Weaver, L L Machen, R C Schadle.   

Abstract

The T-cell colony assay is a highly sensitive measure of immunological dysfunction. The present study evaluated this in vitro response in asymptomatic HIV-infected homosexuals, those with chronic adenopathy as their only clinical manifestation and patients with either ARC or AIDS. The mean colony count in antibody-positive asymptomatic individuals was significantly reduced when compared to either heterosexual controls or antibody-negative homosexuals. Furthermore, there were no differences in the responses of these antibody-positive individuals and those with chronic lymphadenopathy as their only clinical manifestation. By contrast, patients with AIDS or ARC showed a profound defect; this suggests that the colony assay can detect a functional gradient across the spectrum of HIV infections. Colony growth was correlated with the absolute number of T-helper cells and the ability of PHA-stimulated lymphocytes to express IL-2 receptors; no correlation was found with the number of suppressor/cytotoxic cells or in vitro production of IL-2. Recent HIV seroconverters had normal colony counts but impaired ability to express IL-2 receptors. These data suggest a sequential loss of T-cell function as a result of HIV infection; the earliest manifestations are impaired expression of IL-2 receptors and reduced proliferative responses, as measured in the colony assay.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968201      PMCID: PMC1541669     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity.

Authors:  F P Siegal; C Lopez; P A Fitzgerald; K Shah; P Baron; I Z Leiderman; D Imperato; S Landesman
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 2.  NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations.

Authors:  A S Fauci; A M Macher; D L Longo; H C Lane; A H Rook; H Masur; E P Gelmann
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

3.  Generalized lymphadenopathy in homosexual men.

Authors:  C E Metroka; S Cunningham-Rundles; M S Pollack; J A Sonnabend; J M Davis; B Gordon; R D Fernandez; J Mouradian
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

4.  Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma.

Authors:  R W Schroff; M S Gottlieb; H E Prince; L L Chai; J L Fahey
Journal:  Clin Immunol Immunopathol       Date:  1983-06

5.  Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome.

Authors:  H W Murray; B Y Rubin; H Masur; R B Roberts
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

6.  Lymphadenopathies in homosexual men. Relationships with the acquired immune deficiency syndrome.

Authors:  H L Ioachim; C W Lerner; M L Tapper
Journal:  JAMA       Date:  1983-09-09       Impact factor: 56.272

7.  Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2.

Authors:  N Ciobanu; K Welte; G Kruger; S Venuta; J Gold; S P Feldman; C Y Wang; B Koziner; M A Moore; B Safai
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

8.  Depressed T cell colony growth in systemic lupus erythematosus.

Authors:  M L Bernstein; A Winkelstein; S A Dobson
Journal:  Arthritis Rheum       Date:  1980-04

9.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.

Authors:  J L Fahey; H Prince; M Weaver; J Groopman; B Visscher; K Schwartz; R Detels
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

10.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more
  7 in total

Review 1.  A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection.

Authors:  S C Piscitelli; N Bhat; A Pau
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

2.  Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.

Authors:  M Allouche; Y Lunardi-Iskandar; C Varela-Millot; M Itzhaki; P Cornuet; P Meyer; C Jasmin; V Georgoulias
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.

Authors:  E Barker; C E Mackewicz; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

4.  Induction of apoptosis in a T lymphoblastoid cell line infected with feline immunodeficiency virus.

Authors:  K Ohno; Y Okamoto; T Miyazawa; T Mikami; T Watari; R Goitsuka; H Tsujimoto; A Hasegawa
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion.

Authors:  P U Cameron; U Forsum; H Teppler; A Granelli-Piperno; R M Steinman
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

6.  Apoptosis in feline panleukopenia virus-infected lymphocytes.

Authors:  Y Ikeda; J Shinozuka; T Miyazawa; K Kurosawa; Y Izumiya; Y Nishimura; K Nakamura; J Cai; K Fujita; K Doi; T Mikami
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  2-Mercaptoethanol and n-acetylcysteine enhance T cell colony formation in AIDS and ARC.

Authors:  J Wu; E M Levy; P H Black
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.